Vascular ischemia/reperfusion injury (IRI) contributes to graft failure and adverse clinical outcomes following coronary artery bypass grafting. Sodium-glucose-cotransporter (SGLT)-2-inhibitors have been shown to protect against myocardial IRI, irrespective of diabetes. We hypothesized that adding canagliflozin (CANA) (an SGLT-2-inhibitor) to saline protects vascular grafts from IRI.
View Article and Find Full Text PDFObjective: To estimate if women with preeclampsia had measurable differences in the brachial artery waveforms after blood flow occlusion.
Methods: In a cross-sectional study, 14 preeclamptic and 28 matched normotensive women were assessed. Hemolysis, elevated liver enzymes, low platelets syndrome patients were excluded.